Intracortical GABAergic dysfunction in patients with fatigue and dysexecutive syndrome after COVID-19
Autor: | Davide Ferrazzoli, Giacomo Koch, Viviana Versace, Leopold Saltuari, Markus Kofler, Valentina Ajello, Roberto Romanello, Luca Sebastianelli, Francesco Porrazzini, Alessia D'Acunto, Paola Ortelli, Antonio Oliviero |
---|---|
Rok vydání: | 2021 |
Předmět: |
Male
SAI short-latency afferent inhibition medicine.medical_specialty medicine.medical_treatment FRS Fatigue Rating Scale Audiology Article 050105 experimental psychology SICI short-interval intracortical inhibition NO Executive functions GABA 03 medical and health sciences 0302 clinical medicine LICI long-interval intracortical inhibition Rating scale Physiology (medical) Humans Medicine Cognitive Dysfunction 0501 psychology and cognitive sciences GABAergic Neurons Pathological Fatigue Aged Aged 80 and over Dysexecutive syndrome FAB frontal assessment battery business.industry TMS transcranial magnetic stimulation 05 social sciences Motor Cortex COVID-19 Cognition Middle Aged Transcranial Magnetic Stimulation GABA gamma aminobutyric acid Sensory Systems Transcranial magnetic stimulation Neurology TMS COVID-19 TMS GABA Fatigue Executive functions Female Neurology (clinical) Primary motor cortex business 030217 neurology & neurosurgery Executive dysfunction |
Zdroj: | Clinical Neurophysiology |
ISSN: | 1388-2457 |
Popis: | Objective A high proportion of patients experience fatigue and impairment of cognitive functions after coronavirus disease 2019 (COVID-19). Here we applied transcranial magnetic stimulation (TMS) to explore the activity of the main inhibitory intracortical circuits within the primary motor cortex (M1) in a sample of patients complaining of fatigue and presenting executive dysfunction after resolution of COVID-19 with neurological manifestations. Methods Twelve patients who recovered from typical COVID-19 pneumonia with neurological complications and complained of profound physical and mental fatigue underwent, 9 to 13 weeks from disease onset, a psychometric evaluation including a self-reported fatigue numeric-rating scale (FRS, Fatigue Rating Scale) and the Frontal Assessment Battery (FAB). Intracortical activity was evaluated by means of well-established TMS protocols including short-interval intracortical inhibition (SICI), reflecting GABAA-mediated inhibition, long-interval intracortical inhibition (LICI), a marker of GABAB receptor activity, and short-latency afferent inhibition (SAI) that indexes central cholinergic transmission. TMS data were compared to those obtained in a control group of ten healthy subjects (HS) matched by age, sex and education level. Results Post-COVID-19 patients reported marked fatigue according to FRS score (8.1 ± 1.7) and presented pathological scores at the FAB based on Italian normative data (12.2 ± 0.7). TMS revealed marked reduction of SICI, and disruption of LICI as compared to HS. SAI was also slightly diminished. Conclusions The present study documents for the first time reduced GABAergic inhibition in the M1 in patients who recovered from COVID-19 with neurological complications and manifested fatigue and dysexecutive syndrome. Significance TMS may serve as diagnostic tool in cognitive disturbances and fatigue in post-COVID-19 patients. |
Databáze: | OpenAIRE |
Externí odkaz: |